Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Apr 2008 for VION PHARMACEUTICALS INC.
Insider track record
Disclosed buys
9
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Positive at T+90
33%
Median T+90
-53.9%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +38.2%Entry US$47,749.71 · Close at T+365 US$66,010.58
- -4.8%Entry US$54,289.07 · Close at T+365 US$51,698.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Hahne: trading record in brief
Filings by William Hahne span 2 companies, the busiest being Imunon, Inc. and Vion Pharmaceuticals Inc. In total, 11 filings cover trades dated from 14 March 2006 to 1 April 2008.
No open-market sale appears; the market trades are 9 purchases worth €32k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.
In size, the median ticket on the buying side is €2,696. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -53.9%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 3 April 2008: a share grant, in Vion Pharmaceuticals Inc. The most recent open-market purchase was published on 27 February 2007, 7,179 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William Hahne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
20,000 shares0Common StockSEC:0001005477-08-002689:0
6,000 shares@ US$3.55Common StockSEC:0001181431-07-014863:0
Canonical exit: 24 May 2007 (T+90)
5,100 shares@ US$2.44Common StockSEC:0000749647-06-000016:0
300 shares@ US$3.75Common StockSEC:0000749647-06-000014:0
Canonical exit: 10 Aug 2006 (T+90)
1,700 shares@ US$3.75Common StockSEC:0000749647-06-000014:1
Canonical exit: 10 Aug 2006 (T+90)
800 shares@ US$4.20Common StockSEC:0001350065-06-000007:0
Canonical exit: 18 Jun 2006 (T+90)
200 shares@ US$4.19Common StockSEC:0001350065-06-000007:1
Canonical exit: 18 Jun 2006 (T+90)
200 shares@ US$4.05Shares of Common StockSEC:0001350065-06-000005:0
Canonical exit: 12 Jun 2006 (T+90)
800 shares@ US$4.05Shares of Common StockSEC:0001350065-06-000005:1
Canonical exit: 12 Jun 2006 (T+90)
9 of 9 declarations
